X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Dr. Reddys with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs ADCOCK INGRAM (S. Africa) - Comparison Results

DR. REDDYS LAB    Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. REDDYS LAB   ADCOCK INGRAM
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-17
ADCOCK INGRAM
Jun-14
DR. REDDYS LAB/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs3,397360-   
Low Rs2,560259-   
Sales per share (Unadj.) Rs856.5107.0-  
Earnings per share (Unadj.) Rs78.0-27.0-  
Cash flow per share (Unadj.) Rs139.9-22.3-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs739.884.0-  
Shares outstanding (eoy) m165.74168.78-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x3.52.9 120.2%   
Avg P/E ratio x38.2-11.5 -332.7%  
P/CF ratio (eoy) x21.3-13.9 -153.6%  
Price / Book Value ratio x4.03.7 109.2%  
Dividend payout %25.70-   
Avg Mkt Cap Rs m493,63252,238 945.0%   
No. of employees `00022.74.3 528.3%   
Total wages/salary Rs m31,0683,279 947.6%   
Avg. sales/employee Rs Th6,259.04,205.5 148.8%   
Avg. wages/employee Rs Th1,369.8763.7 179.4%   
Avg. net profit/employee Rs Th569.7-1,059.7 -53.8%   
INCOME DATA
Net Sales Rs m141,96118,054 786.3%  
Other income Rs m1,715126 1,356.5%   
Total revenues Rs m143,67618,181 790.3%   
Gross profit Rs m24,722-3,129 -790.2%  
Depreciation Rs m10,266779 1,317.5%   
Interest Rs m634489 129.6%   
Profit before tax Rs m15,537-4,271 -363.8%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m3490-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,965267 1,111.1%   
Profit after tax Rs m12,921-4,549 -284.0%  
Gross profit margin %17.4-17.3 -100.5%  
Effective tax rate %19.1-6.2 -305.4%   
Net profit margin %9.1-25.2 -36.1%  
BALANCE SHEET DATA
Current assets Rs m96,83713,223 732.3%   
Current liabilities Rs m84,1997,440 1,131.7%   
Net working cap to sales %8.932.0 27.8%  
Current ratio x1.21.8 64.7%  
Inventory Days Days73111 66.1%  
Debtors Days Days98124 78.8%  
Net fixed assets Rs m102,5527,708 1,330.5%   
Share capital Rs m82984 989.0%   
"Free" reserves Rs m121,7920-   
Net worth Rs m122,62114,171 865.3%   
Long term debt Rs m5,4494,980 109.4%   
Total assets Rs m218,16526,770 815.0%  
Interest coverage x25.5-7.7 -329.9%   
Debt to equity ratio x00.4 12.6%  
Sales to assets ratio x0.70.7 96.5%   
Return on assets %6.2-15.2 -41.0%  
Return on equity %10.5-32.1 -32.8%  
Return on capital %12.9-19.8 -65.1%  
Exports to sales %54.60-   
Imports to sales %9.40-   
Net fx Rs m55,3150-   
CASH FLOW
From Operations Rs m21,4441,541 1,391.5%  
From Investments Rs m-18,404-473 3,889.4%  
From Financial Activity Rs m-3,6924,520 -81.7%  
Net Cashflow Rs m-1,1445,587 -20.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.96 Rs / ZAR

Compare DR. REDDYS LAB With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare DR. REDDYS LAB With: PFIZER  J.B.CHEMICALS  MERCK LTD  NATCO PHARMA  SUN PHARMA  



Today's Market

Sensex up 200 Points; Realty Stocks Gain(12:30 pm)

After opening the day in green, share markets in India witnessed positive trading activity throughout the day and are presently trading above the dotted line.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Jun 20, 2018 01:21 PM

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 8-QTR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS